SynthesisAesthetic plastic surgery2026
Benefits and Safety of Isotretinoin in Rhinoplasty for Thick-Skinned Patients: A Systematic Review.
Synthesis in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRhinoplasty enhances nasal aesthetics and function but faces challenges in thick-skinned patients due to limited contour definition and higher risks of scarring and complications. Isotretinoin shows promise in reducing skin thickness and improving healing, but its side effects necessitate careful monitoring.
aimTo consolidate existing evidence on isotretinoin efficacy, safety, and impact on satisfaction to guide decision-making for this patient population.
methodsWe retrieved relevant articles up to December 2024 from PubMed, Scopus, Web of Science, and Cochrane Library. Data were extracted from eligible studies by two independent reviewers, including baseline information, type of surgery, isotretinoin regimen, study outcomes, and complications.
resultsHigher satisfaction was found with isotretinoin use post-rhinoplasty at three and six months post-op; however, satisfaction often declined by 12 months. Isotretinoin improved cosmetic results, reducing skin thickness and enhancing nasal definition for up to six months. Nonetheless, differences in outcomes between intervention and control groups diminished by one year. Complications like dryness were common but manageable, while systemic side effects were rare.
conclusionIsotretinoin offers short-term benefits after rhinoplasty for thick-skinned patients, with diminishing effects by one year. Similar efficacy was noted for both oral and topical formulations, favoring topical formulations for their milder side effects. LEVEL OF EVIDENCE I: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
41145858What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.